These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32666479)

  • 1. Leprosy surveillance study in a highly endemic Brazilian area using leprosy specific serologic tests and IFNγ whole blood assay.
    do Carmo Gonçalves A; Hungria EM; Freitas AA; Sékula-Bührer S; Gomes CM; Coelho AC; Nascimento LB; de Araújo Stefani MM
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2345-2360. PubMed ID: 32666479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
    Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
    Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Mycobacterium Leprae-specific cellular and serological tests for the differential diagnosis of leprosy from confounding dermatoses.
    Freitas AA; Hungria EM; Costa MB; Sousa AL; Castilho ML; Gonçalves HS; Pontes MA; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):163-8. PubMed ID: 27506457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.
    Hungria EM; Freitas AA; Pontes MA; Gonçalves HS; Sousa AL; Costa MB; Castilho ML; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):328-334. PubMed ID: 28126361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
    Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antigen serologic tests in leprosy: implications for epidemiological surveillance of leprosy cases and household contacts.
    Carvalho APM; Coelho ADCO; Correa-Oliveira R; Lana FCF
    Mem Inst Oswaldo Cruz; 2017 Sep; 112(9):609-616. PubMed ID: 28902286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.
    Freitas AA; Oliveira RM; Hungria EM; Cardoso LP; Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):154-61. PubMed ID: 26233487
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpectedly high leprosy seroprevalence detected using a random surveillance strategy in midwestern Brazil: A comparison of ELISA and a rapid diagnostic test.
    Frade MA; de Paula NA; Gomes CM; Vernal S; Bernardes Filho F; Lugão HB; de Abreu MM; Botini P; Duthie MS; Spencer JS; Soares RC; Foss NT
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005375. PubMed ID: 28231244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel integrated molecular and serological analysis method to predict new cases of leprosy amongst household contacts.
    Gama RS; Souza MLM; Sarno EN; Moraes MO; Gonçalves A; Stefani MMA; Garcia RMG; Fraga LAO
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007400. PubMed ID: 31181059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.